Neurobiology of schizophrenia

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annals of Neurology

• Publication date

  2000-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/1531-8249(200010)48:4<556::AID-ANA2>3.0.CO;2-2PMID 11026439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural brain abnormalities in patients with schizophrenia and their healthy siblings.

  2000cited by this paper
• Direct protein–protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors

  2000cited by this paper
• Schizophrenia: genes and environment

  2000cited by this paper
• Search for schizophrenia susceptibility genes.

  2000cited by this paper
• Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia.

  2000cited by this paper
• Network interactions in schizophrenia - therapeutic implications.

  2000cited by this paper
• Sustained attention deficits as markers of genetic susceptibility to schizophrenia.

  2000cited by this paper
• The NIMH perspective: next steps in schizophrenia research.

  2000cited by this paper
• Neurologic signs of cerebellar and cortical sensory dysfunction in schizophrenics and their relatives.

  1999cited by this paper
• The neuropathology of schizophrenia. A critical review of the data and their interpretation.

  1999cited by this paper
• Deficit psychopathology and a paradigm shift in schizophrenia research.

  1999cited by this paper
• [Disorders in cognition and language vs. communication deviances in families of schizophrenics].

  1999cited by this paper
• Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls.

  1999cited by this paper
• The factor structure of schizophrenia spectrum personality disorders: signs and symptoms in relatives of psychotic patients from the UCLA family members study

  1999cited by this paper
• Communication disturbances in relatives beyond the age of risk for schizophrenia and their associations with symptoms in patients.

  1999cited by this paper
• Prediction of neuropsychological performance by neurological signs in schizophrenia.

  1999cited by this paper
• Structural brain imaging in schizophrenia: a selective review.

  1999cited by this paper
• A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly.

  1999cited by this paper
• Lack of normal pattern of cerebral asymmetry in familial schizophrenic patients and their relatives--The Maudsley Family Study.

  1999cited by this paper
• Do schizophrenia and affective disorder share susceptibility genes?

  1999cited by this paper
• Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia

  1999cited by this paper
• Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives.

  1999cited by this paper
• Ethnicity and outcome of psychosis

  1999cited by this paper
• The reduced neuropil hypothesis: a circuit based model of schizophrenia.

  1999cited by this paper
• Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism.

  1998cited by this paper
• Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

  1998cited by this paper
• Functional Magnetic Resonance Imaging Brain Mapping in Psychiatry: Methodological Issues Illustrated in a Study of Working Memory in Schizophrenia

  1998cited by this paper
• The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes.

  1998cited by this paper
• Axon terminals of the chandelier class of cortical GABA neurons

  1998cited by this paper
• Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.

  1998cited by this paper
• Long-term outcome studies of schizophrenia: do females continue to display better outcome as expected?

  1997cited by this paper
• Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia.

  1997cited by this paper
• Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

  1997cited by this paper
• Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder

  1997cited by this paper
• Assessment of International Psychogeriatrics: The Journal of the International Psychogeriatric Association

  1997cited by this paper
• Update on treatment strategies

  1997cited by this paper
• On the nature and mechanisms of obstetric influences in schizophrenia: a review and synthesis of epidemiologic studies

  1997cited by this paper
• Dynamic neuroimaging with PET, SPET or fMRI

  1997cited by this paper
• Sex differences in schizophrenia: epidemiology, genetics and the brain

  1997cited by this paper
• Eye tracking dysfunction and schizophrenia: an overview with special reference to the genetics of schizophrenia

  1997cited by this paper
• Cognitive changes in schizophrenia-a critical look

  1997cited by this paper
• Can biological markers identify endophenotypes predisposing to schizophrenia

  1997cited by this paper
• Dementia in elderly schizophrenic patients: reviewing the reviews

  1997cited by this paper
• Update of high-risk research: 1987-1997

  1997cited by this paper
• The Glutamatergic Dysfunction Hypothesis for Schizophrenia

  1996cited by this paper
• Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology.

  1996cited by this paper
• Schizophrenia after prenatal famine. Further evidence.

  1996cited by this paper
• Cerebral lateralization is delayed in children who later develop schizophrenia.

  1996cited by this paper
• High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.

  1996cited by this paper
• Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach.

  1996cited by this paper
• Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease.

  1996cited by this paper
• Serotonin-dopamine interaction and its relevance to schizophrenia.

  1996cited by this paper
• Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study.

  1995cited by this paper
• Spatial working memory deficits in the relatives of schizophrenic patients.

  1995cited by this paper
• Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.

  1995cited by this paper
• A functional neuroanatomy of hallucinations in schizophrenia

  1995cited by this paper
• Childhood precursors of psychosis as clues to its evolutionary origins.

  1995cited by this paper
• Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11

  1994cited by this paper
• Season of birth and obstetrical complications in schizophrenics.

  1994cited by this paper
• Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment.

  1994cited by this paper
• Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

  1994cited by this paper
• Eye tracking and schizophrenia: a selective review.

  1994cited by this paper
• Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results.

  1994cited by this paper
• Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors.

  1993cited by this paper
• Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study.

  1993cited by this paper
• Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development.

  1993cited by this paper
• A neurodevelopmental approach to the classification of schizophrenia.

  1992cited by this paper
• Childhood Attentional Dysfunctions Predict Social Deficits in Unaffected Adults at Risk for Schizophrenia

  1992cited by this paper
• Evidence for a Pseudoautosomal Locus for Schizophrenia

  1992cited by this paper
• Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees.

  1991cited by this paper
• Prediction of adult-onset schizophrenia from childhood home movies of the patients.

  1990cited by this paper
• Thought disorder in the relatives of psychotic patients.

  1989cited by this paper
• Offspring of monozygotic twins discordant for schizophrenia.

  1989cited by this paper
• Splitting schizophrenia

  1988cited by this paper
• A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins.

  1988cited by this paper
• Implications of normal brain development for the pathogenesis of schizophrenia.

  1987cited by this paper
• Early manifestations and first-contact incidence of schizophrenia in different cultures: A preliminary report on the initial evaluation phase of the WHO Collaborative Study on Determinants of Outcome of Severe Mental Disorders

  1986cited by this paper
• The interaction between GABA and dopamine: implications for schizophrenia.

  1983cited by this paper
• The viral hypothesis of schizophrenia.

  1976cited by this paper

• 5-HTTLPR Polymorphism of SLC6A4 Gene and Risk for Schizophrenia: A Case–control Study from North Bengal, India

  2026cites this paper
• Differential DNA-methylation of synaptic genes in CSF and blood in schizophrenia.

  2026cites this paper
• Bibliometric Insights Into the Dynamics of Schizophrenia and Obesity Research

  2025cites this paper
• N-acetylcysteine enhances the antipsychotic effect of aripiprazole in the neurodevelopmental rat model of schizophrenia.

  2025cites this paper
• Altered Cortical Gyrification Is Associated with Cortical and White Matter Microstructure in Individuals with Early Psychosis: A Multimodal Neuroimaging Study.

  2025cites this paper
• Epidural pre-formed long-acting implants as a novel and challenging approach for brain drug delivery.

  2025cites this paper
• IUPHAR Review - Novel therapeutic targets for schizophrenia treatment: a translational perspective.

  2025cites this paper
• Psychiatric comorbidity in substance use disorders, a systematic review of neuro-imaging findings.

  2025cites this paper
• Magnesium and Zinc in Schizophrenia

  2025cites this paper
• Genetic liability to major psychiatric disorders contributes to multi-faceted quality of life outcomes in children and adults

  2025cites this paper
• What value do NMDA receptor antagonist models of schizophrenia have for novel drug discovery?

  2025cites this paper
• Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy.

  2025cites this paper
• Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patients

  2025cites this paper
• Genetic risk and transdiagnostic traits in anorexia nervosa, obsessive-compulsive disorder, and schizophrenia

  2025cites this paper
• Targeting Neuroinflammation in Schizophrenia: A comprehensive review of mechanisms and pharmacological interventions.

  2025cites this paper
• Preliminary Data Regarding the Alleviating Effects of Haloperidol and Risperidone on the Short-Term Memory and Associative Learning in a Zebrafish Model of Schizophrenia

  2025cites this paper
• Understanding Stigma in Mental Illness: A Novel Literature-Based Model of Development

  2025cites this paper
• G Protein-Coupled Receptor Heteromers in Brain: Functional and Therapeutic Importance in Neuropsychiatric Disorders.

  2025cites this paper
• Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation

  2025cites this paper
• Advancing Clinical Neuroassessment: The BrainView ERP Platform in Schizophrenia

  2025cites this paper
• Excess Wnt in neurological disease

  2025cites this paper
• Editorial: Neuroimaging in psychiatry 2023: schizophrenia

  2025cites this paper
• A Multi-Omics Integration Framework with Automated Machine Learning Identifies Peripheral Immune-Coagulation Biomarkers for Schizophrenia Risk Stratification

  2025cites this paper
• Advanced nanoparticle-enabled risperidone delivery for improved therapeutic outcomes of schizophrenia management: a review

  2025cites this paper
• Alterations of serum neuropeptide levels and their relationship to cognitive impairment and psychopathology in male patients with chronic schizophrenia

  2024cites this paper
• Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents

  2024cites this paper
• Parvalbumin Interneuron Disorders Triggered by Oxidative Stress as a Common Mechanism Causing Schizophrenia in the Elderly: a Literature Review Study

  2024cites this paper
• What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia

  2024cites this paper
• Bridging cholinergic signalling and inflammation in schizophrenia

  2024cites this paper
• Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders

  2024cites this paper
• State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons

  2024cites this paper
• Schizophrenia and Bone Marrow Disorders: An Emerging Clinical Association

  2024cites this paper
• Large-scale coupling of prefrontal activity patterns as a mechanism for cognitive control in health and disease: evidence from rodent models

  2024cites this paper
• Impact of cannabinoids on synapse markers in an SH-SY5Y cell culture model

  2024cites this paper
• Acute Behavioral and Neurochemical Effects of Sulpiride in Adult Zebrafish

  2024cites this paper
• The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders

  2024cites this paper
• Establishment of a Mitochondrial Metabolism-Related Diagnostic Model in Schizophrenia Based on LASSO Algorithm

  2024cites this paper
• Parental kynurenine 3-monooxygenase genotype in mice directs sex-specific behavioral outcomes in offspring

  2024cites this paper
• Calciopathies and Neuropsychiatric Disorders: Physiological and Genetic Aspects

  2023cites this paper
• Effectiveness of Mindfulness Based Interventions in Male Schizophrenia Patients

  2023cites this paper
• Prenatal Exposition to Haloperidol: A Preclinical Narrative Review.

  2023cites this paper
• Endorsement of psychotic-like experiences and problematic cannabis use associated with worse executive functioning performance in undergraduates.

  2023cites this paper
• Widespread RNA hypoediting in schizophrenia and its relevance to mitochondrial function

  2023cites this paper
• G protein-coupled estrogen receptor 1 deficiency impairs adult hippocampal neurogenesis in mice with schizophrenia.

  2023cites this paper
• Transferosome-Based Intranasal Drug Delivery Systems for the Management of Schizophrenia: a Futuristic Approach

  2023cites this paper
• Psychiatric adverse reactions to non-selective RET multi-kinase inhibitors: a large-scale pharmacovigilance analysis

  2023cites this paper
• ШИЗОФРЕНИЯНЫҢ ПАТОФИЗИОЛОГИЯСЫ ЖӘНЕ МОЛЕКУЛАЛЫҚ ГЕНЕТИКАЛЫҚ ТРИГЕРЛЕРІ

  2023cites this paper
• BDNF and Cognitive Function in Chilean Schizophrenic Patients

  2023cites this paper
• The impact of early life stress and schizophrenia on motor and cognitive functioning: an experimental study

  2023cites this paper
• GluN2D subunit in parvalbumin interneurons regulates prefrontal cortex feed-forward inhibitory circuit and molecular networks relevant to schizophrenia.

  2023cites this paper
• Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice

  2023cites this paper
• Actin-dependent astrocytic infiltration is a key step for axon defasciculation during remodeling

  2023cites this paper
• Calciopathies and Neuropsychic Disorders: Physiological and Genetic Aspects

  2023cites this paper
• Elucidation of the mechanisms underlying tumor aggravation by the activation of stress-related neurons in the paraventricular nucleus of the hypothalamus

  2023cites this paper
• Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia

  2023cites this paper
• Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies

  2023cites this paper
• The Long Non-Coding RNA GOMAFU in Schizophrenia: Function, Disease Risk, and Beyond

  2022cites this paper
• Nonlinear functional network connectivity in resting functional magnetic resonance imaging data

  2022cites this paper
• Lexical indicators of anxiety in schizophrenia

  2022cites this paper
• Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment

  2022cites this paper
• Vitaminlerin psikiyatrideki rolü: Bir gözden geçirme

  2022cites this paper
• Open chain conjugated azomethine derived optical biosensor for selective and ultrasensitive colorimetric detection of biomarker glutathione in human blood serum

  2022cites this paper
• Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety

  2022cites this paper
• GSK3β and mTORC1 Represent 2 Distinct Signaling Markers in Peripheral Blood Mononuclear Cells of Drug-Naive, First Episode of Psychosis Patients

  2022cites this paper
• Early-stage visual perception impairment in schizophrenia, bottom-up and back again

  2022cites this paper
• Effects of electroconvulsive therapy on certain attention tests in patients with schizophrenia

  2022cites this paper
• Are the measurement structures of the Traditional Chinese Dispositional Flow Scale-2 equivalent between schizophrenic patients and healthy subjects?

  2022cites this paper
• Effect of Atypical Antipsychotics on Serum BDNF in an Egyptian First Samples of First Episode Schizophrenia Patients

  2022cites this paper
• COMT, DRD1, DRD2, DRD4: Genetic evidence for the dopamine hypothesis in schizophrenia

  2022cites this paper
• Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta‐analysis of randomized, double‐blind, placebo‐controlled trials

  2022cites this paper
• Schizophrenia-associated Mitotic Arrest Deficient-1 (MAD1) regulates the polarity of migrating neurons in the developing neocortex

  2022cites this paper
• The Effect of Glutathione Deficit During Early Postnatal Brain Development on the Prepulse Inhibition and Monoamine Levels in Brain Structures of Adult Sprague–Dawley Rats

  2022cites this paper
• Methylation pattern and mRNA expression of synapse-relevant genes in the MAM model of schizophrenia in the time-course of adolescence

  2022cites this paper
• Gold nanoclusters eliminate obesity induced by antipsychotics

  2022cites this paper
• Role of interaction of mGlu2 and 5-HT2A receptors in antipsychotic effects.

  2022cites this paper
• The role of integrin beta in schizophrenia: a preliminary exploration

  2022cites this paper
• Roles of neuroligins in central nervous system development: focus on glial neuroligins and neuron neuroligins

  2022cites this paper
• Cerebral, Psychosocial, Family Functioning and Disability of Persons with Schizophrenia

  2022cites this paper
• Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation

  2022influential citation
• Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous Disc1 Mutant Mice, a Putative Prodromal Schizophrenia Animal Model

  2022cites this paper
• Paliperidone alleviates MK-801-induced damage to prefrontal cortical neurons via the PP2A/PTEN pathway.

  2022cites this paper
• Neurobiology of Schizophrenia: A Comprehensive Review

  2022cites this paper
• Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very late-onset schizophrenia-like psychosis: An update

  2022cites this paper
• Impaired migration of autologous induced neural stem cells from patients with schizophrenia and implications for genetic risk for psychosis.

  2022cites this paper
• Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases.

  2022cites this paper
• Effects of Pilates-Based Exercises on Functional Capacity and Mental Health in Individuals with Schizophrenia: A Pilot Study

  2021cites this paper
• Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex

  2021cites this paper
• Interneuron Heterotopia in the Lis1 Mutant Mouse Cortex Underlies a Structural and Functional Schizophrenia-Like Phenotype

  2021cites this paper
• ICAM-Reg: Interpretable Classification and Regression With Feature Attribution for Mapping Neurological Phenotypes in Individual Scans

  2021cites this paper
• Sleep quality impairments in schizophrenia and bipolar affective disorder patients continue during periods of remission: a case-controlled study

  2021cites this paper
• Spirulina platensis reduces the schizophrenic-like symptoms in rat model by restoring altered APO-E and RTN-4 protein expression in prefrontal cortex.

  2021cites this paper
• Maternal high‐sugar diet results in NMDA receptors abnormalities and cognitive impairment in rat offspring

  2021cites this paper
• Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets

  2021cites this paper
• Endocannabinoids and cortical plasticity: CB1R as a possible regulator of the excitation/inhibition balance in health and disease

  2021cites this paper
• Genomic Variation, Evolvability, and the Paradox of Mental Illness

  2021cites this paper
• Stable habituation deficits in the early stage of psychosis: a 2-year follow-up study

  2021cites this paper
• LKB1 and AMPK instruct cone nuclear position to modify visual function

  2021cites this paper
• QEEG Coherence Changes after a Single Dose of Aripiprazole as a Predictor of Short Term Response to Treatment in Schizophrenia

  2021cites this paper
• Schizophrenia Spectrum Disorders

  2021cites this paper
• Dysregulation of phospholipase and cyclooxygenase expression is involved in Schizophrenia

  2021cites this paper